Spots Global Cancer Trial Database for ras wild type
Every month we try and update this database with for ras wild type cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer | NCT04561336 | Metastatic Colo... RAS Wild Type | Avelumab Cetuximab | 18 Years - | University of Campania "Luigi Vanvitelli" | |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | NCT02292758 | Colorectal Aden... RAS Wild Type Stage IV Colore... Stage IVA Color... Stage IVB Color... | Bevacizumab Cetuximab Irinotecan Laboratory Biom... Placebo | 18 Years - | Academic and Community Cancer Research United | |
| Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer | NCT04561336 | Metastatic Colo... RAS Wild Type | Avelumab Cetuximab | 18 Years - | University of Campania "Luigi Vanvitelli" | |
| Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE) | NCT03043950 | Metastatic Colo... RAS Wild-type | Panitumumab | 18 Years - | iOMEDICO AG | |
| Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE) | NCT03043950 | Metastatic Colo... RAS Wild-type | Panitumumab | 18 Years - | iOMEDICO AG | |
| 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab | NCT03300609 | Colorectal Aden... RAS Wild Type Stage III Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... | Panitumumab Oxaliplatin Leucovorin Calc... Fluorouracil Capecitabine Quality-of-Life... Laboratory Biom... | 18 Years - | University of Southern California | |
| Glutamine PET Imaging Colorectal Cancer | NCT03275974 | RAS Wild Type Stage IV Colore... Stage IVA Color... Stage IVB Color... | Carbon C 11 Glu... Fluorine F 18 L... Positron Emissi... Blood Draw | 18 Years - | M.D. Anderson Cancer Center | |
| A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients | NCT01228734 | Metastatic Colo... | Cetuximab Oxaliplatin Folinic Acid 5Fluorouracil | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer | NCT03983993 | Advanced Micros... Metastatic Micr... Microsatellite ... RAS Wild Type Stage IV Colore... MSI-H Colorecta... | Niraparib Panitumumab | 18 Years - | Emory University | |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | NCT02292758 | Colorectal Aden... RAS Wild Type Stage IV Colore... Stage IVA Color... Stage IVB Color... | Bevacizumab Cetuximab Irinotecan Laboratory Biom... Placebo | 18 Years - | Academic and Community Cancer Research United |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
